Prediction model for estimating the survival benefit of adjuvant radiotherapy for gallbladder cancer

Journal of Clinical Oncology

Volumn 26, Issue 13, 2008, Pages 2112-2117

  Wang, Samuel J ^a   Fuller, C David ^a   Kim, Jong Sung ^a   Sittig, Dean F ^a   Thomas Jr , Charles R ^a   Ravdin, Peter M ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BILIARY TRACT SURGERY; BOOTSTRAPPING; CALCULATION; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; COMPUTER PROGRAM; CONTROLLED STUDY; COVARIANCE; DECISION MAKING; FEMALE; GALLBLADDER CANCER; HAZARD ASSESSMENT; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NOMOGRAM; OVERALL SURVIVAL; PREDICTION; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; SEX; TIME SERIES ANALYSIS; VALIDATION PROCESS; ADJUVANT THERAPY; BIOLOGICAL MODEL; CANCER REGISTRY; DECISION SUPPORT SYSTEM; GALLBLADDER TUMOR; MIDDLE AGED; MORTALITY; PATHOLOGY; PATIENT SELECTION; PREDICTION AND FORECASTING; REPRODUCIBILITY; SEX DIFFERENCE; SURVIVAL; TREATMENT OUTCOME; UNITED STATES;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; DECISION MAKING, COMPUTER-ASSISTED; FEMALE; GALLBLADDER NEOPLASMS; HUMANS; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; NEOPLASM STAGING; NOMOGRAMS; PATIENT SELECTION; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RADIOTHERAPY, ADJUVANT; REPRODUCIBILITY OF RESULTS; SEER PROGRAM; SEX FACTORS; SURVIVAL ANALYSIS; TREATMENT OUTCOME; UNITED STATES;

EID: 43749089120     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2007.14.7934     Document Type: Article

References (39)

1. Yee K, Sheppard BC, Domreis J, et al: Cancers of the gallbladder and biliary ducts. Oncology (Williston Park) 16:939-946, 949, 2002
2. Bartlett DL, Ramanathan RK, Deutsch M: Cancer of the biliary tree, in DeVita VT Jr, Hellman S, Rosenberg SA (eds): Cancer: Principles and Practice of Oncology (ed 7). Philadelphia, PA, Lippincott Williams & Wilkins, 2004
3. de Aretxabala X, Roa I, Berrios M, et al: Chemoradiotherapy in gallbladder cancer. J Surg Oncol 93:699-704, 2006
4. Houry S, Barrier A, Huguier M: Irradiation therapy for gallbladder carcinoma: Recent advances. J Hepatobiliary Pancreat Surg 8:518-524, 2001
5. Bosset JF, Mantion G, Gillet M, et al: Primary carcinoma of the gallbladder. Adjuvant postoperative external irradiation. Cancer 64:1843-1847, 1989
6. Kresl JJ, Schild SE, Henning GT, et al: Adjuvant external beam radiation therapy with concurrent chemotherapy in the management of gallbladder carcinoma. Int J Radiat Oncol Biol Phys 52:167-175, 2002
7. Czito BG, Hurwitz HI, Clough RW, et al: Adjuvant external-beam radiotherapy with concurrent chemotherapy after resection of primary gallbladder carcinoma: A 23-year experience. Int J Radiat Oncol Biol Phys 62:1030-1034, 2005
8. Surveillance, Epidemiology, and End Results: Surveillance, Epidemiology, and End Results (SEER) Program SEER*Stat Database: Incidence - SEER 17 Regs Public-Use, Nov 2005 Sub (1973-2003 varying). Bethesda, MD, National Cancer Institute, Division of Cancer Control and Population Sciences, Surveillance Research Program, Cancer Statistics Branch, released April 2006, based on the November 2005 submission
9. Harrell FE: Regression Modeling Strategies. New York, NY, Springer-Verlag, 2001
10. Jarnagin WR, Ruo L, Little SA, et al: Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma: Implications for adjuvant therapeutic strategies. Cancer 98:1689-1700, 2003
11. Freedman AN, Seminara D, Gail MH, et al: Cancer risk prediction models: A workshop on development, evaluation, and application. J Natl Cancer Inst 97:715-723, 2005
12. Kattan MW, Zelefsky MJ, Kupelian PA, et al: Pretreatment nomogram for predicting the outcome of three-dimensional conformal radiotherapy in prostate cancer. J Clin Oncol 18:3352-3359, 2000
13. Diblasio CJ, Kattan MW: Use of nomograms to predict the risk of disease recurrence after definitive local therapy for prostate cancer. Urology 62:9-18, 2003 (suppl 1)
14. Kattan MW, Zelefsky MJ, Kupelian PA, et al: Pretreatment nomogram that predicts 5-year probability of metastasis following three-dimensional conformal radiation therapy for localized prostate cancer. J Clin Oncol 21:4568-4571, 2003
15. Cagiannos I, Karakiewicz P, Eastham JA, et al: A preoperative nomogram identifying decreased risk of positive pelvic lymph nodes in patients with prostate cancer. J Urol 170:1798-1803, 2003
16. Koh H, Kattan MW, Scardino PT, et al: A nomogram to predict seminal vesicle invasion by the extent and location of cancer in systematic biopsy results. J Urol 170:1203-1208, 2003
17. Kattan MW, Eastham JA, Wheeler TM, et al: Counseling men with prostate cancer: A nomogram for predicting the presence of small, moderately differentiated, confined tumors. J Urol 170:1792-1797, 2003
18. Ohori M, Kattan MW, Koh H, et al: Predicting the presence and side of extracapsular extension: A nomogram for staging prostate cancer. J Urol 171: 1844-1849, 2004
19. Stephenson AJ, Scardino PT, Eastham JA, et al: Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. J Clin Oncol 23:7005-7012, 2005
20. Stephenson AJ, Scardino PT, Eastham JA, et al: Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. J Natl Cancer Inst 98:715-717, 2006
21. Stephenson AJ, Kattan MW: Nomograms for prostate cancer. BJU Int 98:39-46, 2006
22. Stephenson AJ, Scardino PT, Kattan MW, et al: Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy. J Clin Oncol 25:2035-2041, 2007
23. Ravdin PM: A computer based program to assist in adjuvant therapy decisions for individual breast cancer patients. Bull Cancer 82:561S-564S, 1995 (suppl 5)
24. Ravdin PM: A computer program to assist in making breast cancer adjuvant therapy decisions. Semin Oncol 23:43-50, 1996 (suppl 2)
25. De Laurentiis M, De Placido S, Bianco AR, et al: A prognostic model that makes quantitative estimates of probability of relapse for breast cancer patients. Clin Cancer Res 5:4133-4139, 1999
26. Ravdin PM, Siminoff LA, Davis GJ, et al: Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer. J Clin Oncol 19:980-991, 2001
27. Baum M, Ravdin PM: Decision-making in early breast cancer: Guidelines and decision tools. Eur J Cancer 38:745-749, 2002
28. Van Zee KJ, Manasseh DM, Bevilacqua JL, et al: A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy. Ann Surg Oncol 10:1140-1151, 2003
29. Fisher TJ, Kirk J, Hopper JL, et al: A simple tool for identifying unaffected women at a moderately increased or potentially high risk of breast cancer based on their family history. Breast 12:120-127, 2003
30. Ravdin PM, Davis GJ: A method for making estimates of the benefit of the late use of letrozole in patients completing 5 years of tamoxifen. Clin Breast Cancer 5:313-316, 2004
31. Tyrer J, Duffy SW, Cuzick J: A breast cancer prediction model incorporating familial and personal risk factors. Stat Med 23:1111-1130, 2004
32. Olivotto IA, Bajdik CD, Ravdin PM, et al: Population-based validation of the prognostic model ADJUVANT! for early breast cancer. J Clin Oncol 23:2716-2725, 2005
33. Rouzier R, Pusztai L, Delaloge S, et al: Nomograms to predict pathologic complete response and metastasis-free survival after preoperative chemotherapy for breast cancer. J Clin Oncol 23:8331-8339, 2005
34. Ravdin P: Adjuvant! Online. http://www.adjuvantonline.com/
35. Cheng SH, Horng CF, Clarke JL, et al: Prognostic index score and clinical prediction model of local regional recurrence after mastectomy in breast cancer patients. Int J Radiat Oncol Biol Phys 64: 1401-1409, 2006
36. Brennan MF, Kattan MW, Klimstra D, et al: Prognostic nomogram for patients undergoing resection for adenocarcinoma of the pancreas. Ann Surg 240:293-298, 2004
37. National Cancer Institute: SEER-Medicare linked database. http://healthservices.cancer.gov/seermedicare
38. Kattan MW: Comparison of Cox regression with other methods for determining prediction models and nomograms. J Urol 170:S6-S9, 2003
39. Chun FK, Karakiewicz PI, Briganti A, et al: A critical appraisal of logistic regression-based nomograms, artificial neural networks, classification and regression-tree models, look-up tables and riskgroup stratification models for prostate cancer. BJU Int 99:794-800, 2007